PureTech Health (PRTC) RNS Announcements

Add to Alert list
Date Time Source Announcement
09 Jan 2025 12:00 PM
RNS
PRTC's LYT-200 Gets Fast Track Designation in AML
08 Jan 2025 12:00 PM
RNS
PureTech to Present at the JP Morgan Conference
06 Jan 2025 07:00 AM
RNS
PureTech Appoints UBS as UK Corporate Broker
16 Dec 2024 07:00 AM
RNS
PRTC's Ph2b in IPF Successful; New SOC Potential
11 Dec 2024 05:30 PM
RNS
Holding(s) in Company
11 Dec 2024 12:05 PM
RNS
PRTC's Seaport Presents Ph1 SPT-300 Data at ACNP
09 Dec 2024 07:00 AM
RNS
PRTC Presents LYT-200 Phase 1b Data in AML at ASH
27 Nov 2024 05:31 PM
RNS
Holding(s) in Company
27 Nov 2024 05:30 PM
RNS
Holding(s) in Company
20 Nov 2024 12:05 PM
RNS
PRTC's Seaport Adds Microsoft and J&J Exec to BOD
05 Nov 2024 12:05 PM
RNS
PRTC's Seaport Adds Biotech Finance Exec as CFO
01 Nov 2024 07:00 AM
RNS
Total Voting Rights
31 Oct 2024 05:00 PM
RNS
Director/PDMR Shareholding
30 Oct 2024 11:00 AM
RNS
PRTC to Present at UBS and Jefferies Conferences
21 Oct 2024 07:00 AM
RNS
PRTC's Seaport Closes $225M Series B Financing
09 Oct 2024 07:00 AM
RNS
PRTC's IPF Patient Research & Ph 2b On Track YE24
01 Oct 2024 12:00 PM
RNS
PRTC to Give 3 Presentations at CHEST 2024 Meeting
27 Sep 2024 07:00 AM
RNS
KarXT/Cobenfy Approved by FDA; PRTC Receives $29M
06 Sep 2024 06:13 PM
RNS
Holding(s) in Company
06 Sep 2024 07:00 AM
RNS
PRTC's Vor Shares New AML Data Validating Approach
28 Aug 2024 07:01 AM
RNS
Half-year Report
28 Aug 2024 07:00 AM
RNS
Results of AGM on 13 June 2024 – Update Statement
22 Aug 2024 07:00 AM
RNS
PRTC Adds Industry Leader to Board of Directors
21 Aug 2024 07:00 AM
RNS
Notice of Results
13 Aug 2024 12:05 PM
RNS
PRTC's Seaport Appoints Global Pharma Exec to BOD
23 Jul 2024 12:05 PM
RNS
PRTC'S Vedanta Expands Leadership Team
01 Jul 2024 05:00 PM
RNS
Holding(s) in Company
27 Jun 2024 05:01 PM
RNS
PDMR Notification RSU Vesting
27 Jun 2024 05:00 PM
RNS
Director/PDMR Shareholding
24 Jun 2024 05:00 PM
RNS
Completion of Tender Offer & Total Voting Rights
24 Jun 2024 07:00 AM
RNS
Result of Tender Offer
20 Jun 2024 07:00 AM
RNS
Director Declaration
18 Jun 2024 12:05 PM
RNS
PRTC's Seaport Appoints Seasoned Execs to Team
13 Jun 2024 05:42 PM
RNS
Result of AGM
07 Jun 2024 05:30 PM
RNS
Holding(s) in Company
06 Jun 2024 05:34 PM
RNS
Result of Meeting
04 Jun 2024 07:00 AM
RNS
Additional Disclosure Re: Tender Offer
03 Jun 2024 07:00 AM
RNS
Total Voting Rights
29 May 2024 01:04 PM
RNS
PRTC's Akili Enters Into Merger Agreement
23 May 2024 12:00 PM
RNS
PRTC to Present at Jefferies Healthcare Conference
21 May 2024 12:05 PM
RNS
PRTC's Vedanta Begins Phase 3 of VE303 in C. diff
20 May 2024 07:00 AM
RNS
Tender Offer
09 May 2024 12:05 PM
RNS
PRTC's Seaport Presents Ph1 and Ph2a SPT-300 Data
07 May 2024 12:05 PM
RNS
PRTC's Seaport Announces Board/Team Appointments
01 May 2024 07:00 AM
RNS
Total Voting Rights
25 Apr 2024 07:00 AM
RNS
Final Results
18 Apr 2024 07:00 AM
RNS
Notice of Results
16 Apr 2024 12:00 PM
RNS
PRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024
11 Apr 2024 12:00 PM
RNS
FDA Grants PRTC's LYT-200 Fast Track Designation
09 Apr 2024 07:00 AM
RNS
PRTC Launches Seaport w/ $100M; Leadership Changes

PureTech Health is a biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange under the ticker PRTC.

PureTech share price launched at 178p in 2015.

UK 100

Latest directors dealings